Cinnarizine

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N07CA02

CAS registry number (Chemical Abstracts Service)

0000298-57-7

Chemical Formula

C26-H28-N2

Molecular Weight

368

Therapeutic Categories

Antiemetic agent

Histamine H₁-receptor antagonist (H₁-antihistaminic)

Antivertigo agent

Chemical Names

trans-1-cinnamyl-4-diphenylmethylpiperazine (WHO)

1-Cinnamyl-4-(diphenylmethyl)piperazine (USAN)

Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)- (USAN)

Foreign Names

Generic Names

  • Cinnarizina (OS: DCIT)
  • Cinnarizine (OS: DCF, USAN, JAN, BAN)
  • 516 MD (IS)
  • 5-23-01-00233 (IS: Beilstein Handbook Reference)
  • BRN 0626121 (IS)
  • R 1575 (IS)
  • R 516 (IS)
  • UNII-3DI2E1X18L (IS)
  • Cinnarizin (PH: Ph. Eur. 7)
  • Cinnarizine (PH: BP 2011, Ph. Eur. 7)
  • Cinnarizinum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)